Cost-effectiveness analysis of aspirin for primary prevention of cardiovascular events among patients with type 2 diabetes in China

The use of aspirin for primary prevention of cardiovascular disease (CVD) in patients with diabetes mellitus (DM) is associated with lower rates of cardiovascular events but increased risks of bleeding complications. We aimed to examine the cost-effectiveness of aspirin therapy for primary preventio...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Minghuan, Li, Pengchao, You, Joyce Hoi-sze, Zheng, Xinglong, Deng, Jizhao, Zhao, Mingyue, Feng, Liuxin, Fang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886850/
https://www.ncbi.nlm.nih.gov/pubmed/31790409
http://dx.doi.org/10.1371/journal.pone.0224580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886850/
https://www.ncbi.nlm.nih.gov/pubmed/31790409
http://dx.doi.org/10.1371/journal.pone.0224580

Ejemplares similares